Clinical Trial

Temporal Interference Stimulation of Hypothalamus in Patients With Narcolepsy Type 1

Study acronym: TINY
Recruiting
View on ClinicalTrials.gov →
Summary
Narcolepsy type 1 (NT1) is a chronic brain disorder caused by selective loss or dysfunction of orexin (hypocretin) neurons in the lateral hypothalamus, for which current pharmacological treatments offer limited efficacy. Temporal interference (TI) stimulation is a recently developed noninvasive neuromodulation technique that enables focal modulation of deep brain structures. In this randomized, double-blind study, we developed a theta-burst patterned TI protocol and evaluated its effects in patients with NT1.
Protocol Amendment History 1 change
critical Recruitment opened 2026-08-06
Trial Details
NCT Number NCT07727239
Lead Sponsor Xijing Hospital
Conditions Narcolepsy Type 1
Enrollment 24 participants
Start Date 2026-08-01
Primary Completion 2027-11-30 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-08-05